16 evolution "https:" "https:" "https:" "https:" "https:" "https:" "ISCTE IUL" uni jobs at Nature Careers in Switzerland
Sort by
Refine Your Search
-
generations to come. Join Roche, where every voice matters. The Position This role is in Early Development Biometrics (EDB), a core function within Product Development Data Sciences (PDD) that provides
-
, preferably Neuroanatomy, and using model systems relevant to human development or disease. You will also be expected to secure competitive research funding and publish high-quality papers in your field
-
-of-the-art facilities and infrastructure, plus a mentorship program. The position is an attractive springboard for scientific and career development. ELISIR scholars are not tenured and appointed
-
may be contacted directly by the committee). Letters of recommendation are not required at this stage. Applications must be submitted exclusively online at https://jobs.unige.ch by 1st March 2026
-
expertise in the use and development of AI-based approaches for image and data analysis. A general understanding of methods for in silico prediction, modeling, or data integration and/or of experimental
-
. Publications in major international peer-reviewed journals. START DATE: October 1st, 2026 or upon agreement Mandatory online registration before February 6th 2026 at: http://www.unige.ch/academ Further enquiries
-
, and emailed to: applications@natdek.unibe.ch . Candidates must also submit the online questionnaire, found at: https://www.iap.unibe.ch/about_us/ (applications are incomplete without this form
-
registration required before February 14th 2026 on http://www.unige.ch/academ For further information, contact: With a view to achieving parity, the University encourages female candidates
-
collaboration with medical research communities in Basel and Zurich. The future Assistant Professor will bring unique, multidisciplinary expertise in computational immunology, contributing to the development
-
generations to come. Join Roche, where every voice matters. The Position In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to